ABSTRACT N-Phenylacetyl-L-phenylalanine (PAP) and L-phenylalanyl-3-aminopyridine (PAPA) are biaromatic agents with properties that make them suitable candidates for the development of a useful therapeutic agent for the treatment-of sickle cell disease. PAP and PAPA are taken up by the erythrocyte to give intra-/extracellular concentration ratios of 2.2 and 1.5, respectively, after a 2-hr exposure period. The intracellular buildup of PAP and PAPA produces moderate decreases in the mean corpuscular hemoglobin concentration (MCHC) of 6 and 10%, respectively, at 3 mM and a further decline in MCHC with increased concentration. Both PAP and PAPA increase the deoxy-Hb S solubility, C,. If Many of the approaches and rationales (1, 2) aimed at the development of chemical agents for the treatment of sickle cell disease have centered on agents that can interact covalently or noncovalently with the Hb S tetramer to increase the delay time of Hb S gelation. With respect to the latter, in vitro studies of small peptides, alkylureas, and amino acids (3-6), aryl-substituted alanines (7), and halogenated aryl derivatives of oxy acids (8) have revealed several general stereochemical criteria associated with antigelation activity for a noncovalent inhibitor. Biaromatic and bicyclic compounds are more effective than monocyclic compounds and aromatic moieties, more so than aliphatic groups. With regard to aromatic nuclei, the higher the degree of ring polarizability and hydrophobicity of the compound, the greater is its antigelation activity. However, little is known of erythrocyte penetration by these compounds except for amino acids and peptides.
PAPA increase the deoxy-Hb S solubility, C,. If the solubility in the absence of the agent is Cso, PAP and PAPA have CQ/CO values of 1.21 and 1.14 at 20 mM, respectively, compared with a value of 1.06 for L-phenylalanine itself. Filterability assays of partially deoxygenated homozygous sickle cells show an increase in cell flexibility of 7 to 16 times more than that of untreated cells when these agents are present at 3-6 mM. These results are largely due to the reduction in the Hb S polymer content of the treated cells. At 3 mM or less, both PAP and PAPA delay the onset of gelation in reversible sickle cells for time periods that are likely to be therapeutically useful.
Many of the approaches and rationales (1, 2) aimed at the development of chemical agents for the treatment of sickle cell disease have centered on agents that can interact covalently or noncovalently with the Hb S tetramer to increase the delay time of Hb S gelation. With respect to the latter, in vitro studies of small peptides, alkylureas, and amino acids (3) (4) (5) (6) , aryl-substituted alanines (7) , and halogenated aryl derivatives of oxy acids (8) have revealed several general stereochemical criteria associated with antigelation activity for a noncovalent inhibitor. Biaromatic and bicyclic compounds are more effective than monocyclic compounds and aromatic moieties, more so than aliphatic groups. With regard to aromatic nuclei, the higher the degree of ring polarizability and hydrophobicity of the compound, the greater is its antigelation activity. However, little is known of erythrocyte penetration by these compounds except for amino acids and peptides.
Another result was found with noncovalent binding compounds in the study of aromatic amino acid esters including L-phenylalanyl benzyl ester (9) and Cetiedil (10, 11) , a tricyclic ester. Both of these compounds induce water uptake by the erythrocyte. The exact mechanism by which the benzyl ester can cause water uptake is not known whereas Cetiedil has been shown to alter cation permeability so as to induce water gain by the cell. The net effect of water uptake, of course, is a reduction in the mean corpuscular hemoglobin concentration (MCHC), with an attendent increase in the delay time for intracellular gelation (12) .
Drawbacks to the benzyl ester of L-phenylalanine are its low solubility and gradual hydrolysis in the cell. We have addressed these problems by synthesizing biaromatic derivatives of L-phenylalanine that are held together by a stable amide bond rather than an ester bond. We report on two such antisickling agents, one of which is N-phenylacetyl-Lphenylalanine (PAP), where the linkage is through the a-amino group of L-phenylalanine. The other is L-phenylalanyl-3-aminopyridine (PAPA), which has a linkage through the carboxyl group of L-phenylalanine. In this paper, we describe properties of both compounds as they relate to their permeability in the erythrocyte, their antigelation activity as measured by deoxy-Hb S solubility, and their effects on the MCHC. In addition, these effects have been used to estimate the intracellular mole fraction of polymerized Hb S and delay times (Od values) for gelation at a fixed 02 saturation.
MATERIALS AND METHODS
The Hb S used in all solubility determinations was obtained from a homozygous sickle cell patient just prior to a necessary exchange transfusion. The blood lysate was treated as described (5) except that it was dialyzed against 50 mM sodium phosphate buffer (pH 7.2). Hb F content was 3.2% as determined by FTEST (Isolab, Akron, OH). The homozygous SS and AA blood was used within 3-24 hr and stored at 40C.
Chemical Synthesis. N-Acetyl-L-phenylalanine (NAP) was prepared according to the method of DeWitt and Ingersoll (13) . 14C-labeled NAP and PAP were prepared by the same methods. NAP was obtained by the reaction of [14C]acetic anhydride with the methyl ester of L-phenylalanine in dry acetonitrile in the presence of triethylamine. The ester was purified on a silica column, eluted off with EtOAc/hexane (1:1), and saponified. PAP was prepared by coupling phenylacetic acid N-hydroxysuccinimide ester with the methyl ester of L-phenylalanine. The resulting ester was purified by chromatography [silica column, elution by EtOAc/hexane (2:3)] and saponified: mp 140-141'C [literature, 138-1390C (14) ]. 14C-labeled PAP was prepared by the same method. Purification of 14C-labeled NAP and PAP was carried out by thin layer chromatography using n-BuOH/HOAc/H20 (4:4:1) as the elutant. RF values were 0.8 and 0.83 for NAP and PAP, respectively. Synthesis of unlabeled PAPA has been described (15) . 14C-labeled L-phenylalanine (New England Nuclear) was used to prepare labeled PAPA, the preparation of which followed that of unlabeled PAPA. Isolation of 14C-labeled PAPA was by the method used for NAP with RF = 0.49.
Incorporation Measurements. Specific activity of the 14C- does not enter the cell was added, and the sample was mixed in a Vortex and centrifuged; and finally the radioactivity (dpm/,l~) for 14C and 3H in the supernatant was determined.
Excess supernatant was then removed and the combined cell suspension and tube were weighed. The erythrocyte suspension was then lysed and bleached according to the protocol procedure from New England Nuclear. The corrected unquenched dpm/,Al values for 14C and 3H of the total lysate were determined using a quenching curve program for double labels executed in a Beckman LS7500 microprocessorcontrolled scintillation counter. The distribution ratio (DR) of intracellular/extracellular concentration of compound was calculated using a cell water content of 72% by cell weight. The distribution ratio is given by
RESULTS AND DISCUSSION
A most difficult problem to solve in the design of useful agents for the treatment of sickle cell disease is the permeability of the compound to the erythrocyte cell wall. The erythrocyte shows a strong discriminatory behavior in its permeability for small organic molecules based on their stereochemical features (16) . To gain some insight into the mechanism governing permeability of PAP and PAPA, measurements were made of their concentration inside the cell divided by that outside (distribution ratio, DR) as a function of time. Measurements were also made for their common constituent L-phenylalanine, as well as for NAP, an analogue of PAP. The results shown in Fig. 1 indicate substantial differences in the rates of uptake and in their equilibrium DR values.
Variations in the rate of cellular uptake by the compounds in Fig. 1 indicate the influence of their net charge and lipid solubility. This is evident in the electrostatic attraction of cationic PAPA to the negative membrane surface, which accounts for the large differences in its initial DR values between washed and unwashed cells in Fig. 1 . Likewise, Lphenylalanine with a net zero charge experiences little elec-
where W, and (dpm, x) are the weight in milligrams of unlysed cell suspension and dpm values for a given radionuclide, x. Subscripts 1 and sn signify lysate and supernatant, respectively. Deoxy-Hb S Solubility Measurements. The equilibrium solubility of deoxy-Hb S (CQ) was determined using a smallsample volume technique (7) with some modifications. At 4°C, solutions of Hb S and those of the compound were placed in 0.8-ml cellulose tubes that were stoppered and flushed with N2 (g), after which 20% Na2S204 in 0.35 M NaOH was added anaerobically. The tubes were inverted continually for 5 min and allowed to stand for 4 min, and the deoxy-Hb S solutions were then overlaid anaerobically with mineral oil. trostatic repulsion and penetrates almost 50 times faster than anionic NAP and 5 times faster than PAP. The latter with its additional lipid-soluble phenyl ring may be able to reduce electrostatic repulsion by using its added apolar ring side to approach and penetrate the membrane whereas NAP cannot do this.
It is likely the molecules transverse the erythrocyte membrane most effectively if they are uncharged. This is strongly suggested by the trend in DR as a function of pH for NAP, PAP, and PAPA shown in Fig. 1 (Fig. 1) . The explanation of this observation cannot be that the cells become leaky; otherwise, the DR would be expected to be 1. One would expect that cells would become somewhat leaky with an increase in the incubation period regardless of the presence of PAPA. This may account largely for the small decline in DR after 3½/2 hr (Fig. 1) when compared with untreated cells.
Additional studies on erythrocyte membranes isolated from previously washed cells treated with '4C-labeled PAP and PAPA, yielded no appreciable 14C activity in the membranes, which indicates that the DR values in Fig. 1 Fig. 1 were carried out with 3 mM PAP or PAPA in the incubation medium. However, revaluation of the DR with an extracellular PAP concentration of 6 mM gave no significant change (<4%) in the DR from that shown in Fig. 1 , which suggests that at least two sites with similar intrinsic affinities for PAP may be present.
The intracellular build-up of PAPA to its equilibrium DR value of 1.5, seen at 2 hr in Fig. 1 , is probably due to two factors. There is a weaker association with Hb than that seen with PAP, and there is a small pH difference (0.2-0.25 unit) existing across the erythrocyte membrane (17) in which the intracellular pH is lower. A small pH difference would, in effect, reduce the efflux of cationic PAPA out of the cell because the estimated pK for an a-NH2 group in a peptide lies between 8 and 8.5 (18) . Both binding to Hb S and the pH difference probably contribute to the DR value of PAPA.
When Hb S is deoxygenated, it aggregates and this can be detected as a decrease in its solubility. An agent that binds to deoxy-Hb S may diminish its aggregation, which is detected by an increase in Hb S solubility in the monomer phase. PAP, PAPA, and L-phenylalanine as functions of concentration. The variation in C°was small and an average value, (C°) = 17.1 + 0.3 g/dl, was found for eight control samples. It is apparent from Fig. 2 that both biaromatic compounds, PAP and PAPA, have a substantially larger antigelation activity than L-phenylalanine. Comparison of the slope of the line for PAP with those for PAPA and L-phenylalanine shows ratios of 1.54 and 3.13, respectively. PAP, as an antigelation agent, is approximately half again more effective than PAPA and 3 times more so than L-phenylalanine at a concentration of 20 mM. The fact that PAP has greater antigelation activity than PAPA indicates strong differences in their ring system interactions with the Hb S tetramer or in their site of interaction leading to stronger binding for PAP. The trend in the magnitude of antigelation activities, PAP > PAPA > phenylalanine, and a similar trend in their equilibrium distribution ratios (DR values) suggest that binding is the major factor governing the uphill concentration across the erythrocyte for the biaromatic agents.
Erythrocyte uptake of a compound may or may not have an effect on the osmotic water balance across the cell membrane as reflected in the measured MCHC value of a cell population. The reestablishment of osmotic balance due to the permeability of a compound can result in swelling or cell shrinkage depending on the magnitude and direction of the permeable anion flux. Curves for the observed untreated/ treated cell ratios (MCHCO/MCHC), after the erythrocytes have been exposed to various concentrations of PAP, PAPA, and L-phenylalanine are shown in Fig. 3 . A linear change in the MCHCO/MCHC ratio per mM concentration change in PAPA was found up to the highest concentration studied, 5.2 mM. PAP shows a smaller rate of increase in the MCHCO/MCHC ratio and the rate rises more slowly above 4 mM to give a ratio of 1.09 near 6 mM (extracellular). In contrast to these results, no measurable effect on MCHCO was found for cells treated with L-phenylalanine.
As mentioned above, it is likely that both PAP and PAPA are uncharged on entering the cell. In the case of PAP, once it is inside the cell it resumes its anionic form by releasing a hydrogen ion so there is internal acidification. In the process of reestablishing pH equilibria, HCO-/Cl-exchange will occur as intracellular HCO-forms CO2 in the more acidic cell medium according to the Jacobs-Stewart cycle (19) . This process will cause cell swelling due to uptake of Clions to establish solution electroneutrality upon the internal displacement of the bicarbonate ions. On the other hand, cell penetration by PAPA followed by cell swelling is analogous to that found with a simple ammonium salt (19) The degree of cellular deformability conferred on treated cells can be measured as the percent recovery ratio, R, which is the ratio of deoxygenated to oxygenated homozygous sickle cells that are able to pass through a small pore membrane. Such filtration experiments were carried out and the recovery ratios of treated cells at 4.1% 02 after being microsieved through a 5-gm-pore-size membrane are given in Table 1 . At 3 and 6 mM PAP, 7-and 14-fold increases, respectively, in R were found compared with the control cells. For PAPA at 3 and 6 mM, 9-and 20-fold increases were observed. Although these changes in R occurred under a high driving pressure necessitated in part by pore plugging and competition by cells at a 1% hematocrit value (22) , the R values indicate a clear increase in cell deformabilitv. The observed cellular flexibility of morphologically reversible sickle cells (those able to pass through the filter membrane) when treated with PAP or PAPA must be related to the average intracellular mole fraction of Hb S polymer, fp. To examine this relationship, we present in Table 1 estimated percentage water gain (w) and estimates offp at 370C
in the presence and absence of cellular swelling. The values offp given were determined using total 02 saturation for untreated cells to give the upper one and basing the lower one on shifts in 02 saturation (AP50 < 1.2 mm Hg; 1 mm Hg = 133 Pa) of Hb S due to changes in MCHC as determined using the data of Gill et al. (23) . As shown, increases in R are accompanied by nonlinear decreases infp. For example, the R values at 3 and 6 mM PAP increase about 2-fold while fp 81 27.5 0.10, 0.02 0.35 -104 Cell filterability, mole fraction of Hb S polymer, and estimated td values for intracellular gelation at 4.1% 02 are given along with estimated cellular water gain. *After passage of cells through the membrane, the recovery ratio, R, was determined as follows: (weight of deoxygenated treated cells/ weight of oxygenated treated cells) x 100. The average of three assays is listed. The apparatus to measure the filterable amount of cells has been described (9) . A gas (4.06% 02/4.4% C02/balance N2) at a positive pressure of 3.5 cm Hg was used to push the cell suspension (2.5 ml, hematocrit value, =1%) through a 2.3-cm-diameter Bio-Rad membrane (5-,Am pore size). The same gas was used to deoxygenate a sample suspension (3.5 ml) by bubbling the gas through the solution at 370C at a flow rate of 1.5 mil/min. Equilibrium deoxygenation was usually complete within 6 min. It was checked at 8 min by Po2 measurement (Radiometer BMS MKS 2) just a few minutes prior to filtration. The cell medium was phosphate-buffered saline (pH 7.4 whereas in the absence of water gain, even at 6 mM, it reduces fp by only 25%.
The effects of the biaromatic agents, PAP and PAPA, on the sickle cell erythrocyte is reflected in the resultant td for intracellular gelation. The td in the presence of a chemical agent is an important parameter for evaluating the potential therapeutic usefulness of the agent. Estimates of td given in Table 1 were based on homozygous SS cells at a fixed MCHC of 0.34 g/ml and an 02 saturation of 44%. As shown, even at 3 mM, PAP or PAPA can produce a 30-fold increase in the td value, as compared with that for untreated cells.
This indicates that even below 3.0 mM these compounds can have therapeutic value in vivo on the reversible cell population (17, 25) at the above-cited 02 tension and MCHC values.
Such changes in td for treated cells are in large measure due to water uptake as for changes infp. This is apparent at 6 mM (Table 1) . PAPA produces only twice the percentage water gain by the cell population as PAP, yet the td value due to PAPA is several orders of magnitude larger than that due to PAP. However, at low inhibitor concentrations, the ability of an agent to increase Hb S solubility is important in determining td; at 3 mM, the water gain due to PAPA is 60% larger than that due to PAP, yet the td values are almost identical (Table 1 
